Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1387508 NEW YORK, NY

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
111,468
+189.4% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 111,468
2025-12-31 38,521
2025-06-30 31,139
2024-12-31 31,255
2024-09-30 28,955
2024-06-30 12,934
2023-12-31 8,240
2023-06-30 2,861
2022-09-30 11,293
2021-06-30 4,434
2021-03-31 15,391
2020-06-30 3,956
2020-03-31 3,508